“CRISPR-Cas9 Genomic Editing as an Innovation in the Management of Sickle Cell Disease: A Systematic Review”, Am. J. Med. Sci. Innov., vol. 2, no. 2, pp. 44–56, Jul. 2023, doi: 10.54536/ajmsi.v2i2.1760.